Verona Pharma Share Discussion Threads

[tradertrev] 06/10/2022 09:37

Testing resistance at the last issue price of $10.50?
Enhance 1 headline data due this quarter.

[tradertrev] 30/9/2022 17:06

Under 10p?? Looking weak again?? What are you talking about? It's gone from $4 to $10 in the last 3-4 months!! Are you on the wrong thread?

[haff1] 30/9/2022 11:44

Now its under 10p this is looking weak again.....as usual...... still jam tomorrow...

[digger18] 25/8/2022 19:40

Agreed, but high confidence in the likely success of Engance 1 and they have already started to prepare for commercialisation.
They also have Dpi and MDI ready to go into P3, but I assume they will go for the profitable bronchodilator COPD maintenance market first. I am not really that concerned about a pull back between now and year end Enhance 1 results, as it would only tempt me to top up again after a partial sell. Good luck all LTH’s - it’s been a long frustrating journey.

[haff1] 25/8/2022 11:35

Whats the betting this will now return to the earlier lower levels... bit by bit?

On a TA approach it had to go back to a 10 region - following the rise - but the lower highs and lower lows now seen are all a bad sign that this is still not going to sustain a rise. It will need to keep above 10 to indicate that....lets see......

[digger18] 19/8/2022 12:45

Yep, especially with the number COPD sufferers in China.

[mo78000] 19/8/2022 08:21

This is hugehttps://www.globenewswire.com/news-release/2022/08/19/2501348/0/en/Nuance-Pharma-receives-Clearance-to-begin-Pivotal-Clinical-Trials-with-Ensifentrine-for-COPD-in-China.html

[digger18] 15/8/2022 21:51

Massive $150m raise, fully subscribed at $10.5 per ADS. Fully backed and funded!

[mo78000] 14/8/2022 22:47

If VRPs past history is anything to go by this will tank in the next week! Hope I'm wrong. LTH

[haroldthegreat] 14/8/2022 21:33

broker target of $25 when ?

[mo78000] 14/8/2022 19:41

https://pharmaphorum.com/news/verona-cues-up-filings-for-copd-drug-after-it-aces-phase-3-test/

[mo78000] 12/8/2022 21:31

Another positive day....just 50% more and il be even....been in this since 2007.

[digger18] 11/8/2022 21:38

This demonstrates high confidence in Enhance 1 and will fund initial marketing.
Broker target is circa $25, but in market, who knows!

[tradertrev] 11/8/2022 15:54

I expect most have seen this, but here it is anyway...

Issue size up from 10m to 12.4m ADRs at $10.50 raising $130m before fees. Greenshoe option of additional 1.84m ADRs, which given a current price of $12 is probably going to be exercised.
This could be the last Verona share issue!!! (Probably not though :-) )

[haroldthegreat] 10/8/2022 23:01

I have the answer from Wikipedia . It was Glaxo !

RPL554 was part of a family of compounds invented by Sir David Jack, former head of R&D for GlaxoSmithKline, and Alexander Oxford, a medicinal chemist; the patents on their work were assigned to Vernalis plc.[4][5][6]: ;19–

Time for Glaxo to get it back and make a bid ,now we have shown them it works .

[haroldthegreat] 10/8/2022 22:53

Well perhaps we might see our money back if there is a takeover , I believe this came from Glaxo when they lost interest in it but I may be wrong . Perhaps they will want it back ?
Actually i want more than my money back i am after an index linked return from date of purchase .
Timbo where did this come from ? After a reply i will not ask any more questions !

[timbo003] 10/8/2022 22:29

>>>HTG

Looking at the chart it looks as if the all time high occurred during Oct 2009 and was about 17p/old ordinary share or 850p/new ordinary share

[haroldthegreat] 10/8/2022 21:18

Thank you Trev for pointing out my error . I took the 5 from 50 by error instead of 400. ! was rushing out at the time .!
Anyway even with the rise today , amazing what a little viagra dose to a share chart ,the correct calculation still is not enough to cure my depression over the massive loss !
So I will have to get some sertraline ,benzodiazepine and alcohol to get to sleep tonight .
The peak appears to have been $20 29/3/2018 but it might have been higher .

Tim another challenge what was the peak price ?

[boystown] 10/8/2022 20:56

Many thanks again timbo003. I guess the potential market is pretty much limitless if they get a genuine breakthrough - so I'll make that a "hold"! :-)

[timbo003] 10/8/2022 19:59

>>>>Boystown

The results from ENHANCE2 were really very good and exceeded my expectations (and probably the expectations of many others, including KOLs)

The exacerbation data (42% reduction) was particularly impressive and this was an improvement vs Standard of Care (LABAs, LAMAs and Steroids) not just placebo.

Others have found it difficult to show reduction in exacerbations, here's just two examples (there are others)

Novatis had to combine data from three large clinicals to get a statistically significant difference for Indercaterol plus SOC vs SOC


Takeda failed to show a significant difference with roflumilast in another large study (roflumilast plus SOC vs SOC)

[tradertrev] 10/8/2022 19:17

HTG - one ADS = 400 old shares
$11 / 1.2 / 400 = 2.29p ... that's already a 38% increase on your 1.66p!!

[boystown] 10/8/2022 18:12

Many thanks timbo003, but it's all Greek to me. Actually, it's worse as I could Google translate Greek! :-)

But a $588m market cap!? Is the Ensifentrine copd drug treatment potential that big? I mean, I know the market is immense, but is Ensifentrine genuinely groundbreaking?

[haroldthegreat] 10/8/2022 13:26

Ignorance is bliss !

[haroldthegreat] 10/8/2022 13:25

so 1 share = £8.30 = 500 old shares so valuing each old share at 1.66 p . Just as well I haven't done the calculation before , too depressing !
I was going to thank you for the information but would have been emotionally better off not to have picked your brains !!!!!

[timbo003] 10/8/2022 12:18

The last two investor presentations are worth a look to help understand the current state of play with respect to size of the opportunity, current startegy and ongoing clinical trials:

June 2022:

Aug 2022: